Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase
about
A liver full of JNK: signaling in regulation of cell function and disease pathogenesis, and clinical approachesMAPK signaling in inflammation-associated cancer developmentJunB Inhibits ER Stress and Apoptosis in Pancreatic Beta CellsSmall molecule inhibitors targeting activator protein 1 (AP-1).Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.The transcription factor c-Jun protects against liver damage following activated β-Catenin signaling.Antioxidant defense and oxidative stress in children with acute hepatitis A.Reparative inflammation takes charge of tissue regeneration.Targeted deletion of Jun/AP-1 in alveolar epithelial cells causes progressive emphysema and worsens cigarette smoke-induced lung inflammationGlucocorticoid-induced microRNA-511 protects against TNF by down-regulating TNFR1.Inhibition of natural killer cells protects the liver against acute injury in the absence of glycine N-methyltransferase.Activator protein-1 regulation of murine aldehyde dehydrogenase 1a1Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation.The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in micec-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice.JUNB/AP-1 controls IFN-γ during inflammatory liver disease.Mouse models for liver cancer.Studying the association of microRNA-210 level with chronic hepatitis B progression.Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells.The transcription factor c-Jun protects against sustained hepatic endoplasmic reticulum stress thereby promoting hepatocyte survival.Dihydromyricetin alleviates carbon tetrachloride-induced acute liver injury via JNK-dependent mechanism in mice.Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.Liver carcinogenesis by FOS-dependent inflammation and cholesterol dysregulationThe CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts.Activator Protein 1 transcription factor Fos-related antigen 1 (Fra-1) is dispensable for murine liver fibrosis, but modulates xenobiotic metabolism.Clinical significance of miRNA-autophagy transcript expression in patients with hepatocellular carcinoma.Hijacking of the AP-1 Signaling Pathway during Development of ATL.The Identification of Pivotal Transcriptional Factors Mediating Cell Responses To Drugs With Drug-Induced Liver Injury Liabilities.Phosphatidylcholine transfer protein/StarD2 promotes microvesicular steatosis and liver injury in murine experimental steatohepatitis.Stromal cell-derived factor-1/CXCR4 promotes IL-6 production in human synovial fibroblasts.Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension
P2860
Q28392033-EE937A02-253A-448D-A30E-D7E643F01A6DQ28394852-DC9DCAD0-0F82-4D33-BBF9-7A3A4B89400CQ28473492-854C112B-D71E-4F8F-9034-3047C458CBA5Q30398272-E7ADFB35-F9C8-4369-9284-14F739EA311CQ33621757-28FC7825-1790-4C61-B329-51B8AAEC452DQ34336646-335FAF56-9CC5-418C-84B5-3337A1CC6DD6Q35059577-2C0B47AF-9F88-4AEB-BCF6-ACE812AEE233Q35899475-B43E9631-DE0A-4BCB-BCD3-2AF40F93CCE5Q35951960-17764E84-D007-4359-8065-A26A1D94525FQ36000791-B0CF7FB4-131D-4E2A-8BA8-CDE73D917466Q36044222-AE170537-8538-47E6-AF96-135FD2B51405Q36294446-76DB9BD7-FEB5-4284-B70F-3D3C83A452CFQ36965134-7FA50132-EF26-4D92-9BC4-6CD039033B9EQ37179302-7D021BF0-66C3-4084-A1BE-8315A0781B62Q37376335-BF3D2383-554F-41FD-B4DA-2375A7E0FFDEQ37384060-EABF1382-FDBB-4265-BACF-04C059BB8A67Q38083387-EEDD739C-AF0A-428A-B8E7-D248CC2610E5Q39018448-09A3B7D2-89BE-480E-BBC8-D7FACCBD3374Q39410853-F5F467EF-141D-4865-AB96-BF957149765AQ39467135-4E53601A-371F-461A-AFEC-C7FF03159D9FQ40545073-A11C0632-A64F-4D40-AB40-3FFB901BC0BBQ40740556-8B84FA47-16A8-4EEC-ABB8-BA9776EAE16DQ42580571-F85C3923-7546-47E2-A01B-CAD06596054EQ42878657-B470AE88-2383-4ED0-A14D-2A70A50E7D15Q44653546-201BAF13-A64A-42B6-A53D-8812D2E450A5Q46446224-198F325C-6442-4142-A47E-640B406EE360Q47548071-CB35B991-75AF-492D-A6A7-E01E5F329061Q47652130-6CDF6D9D-AB0E-4BF8-94C9-DA87F330242AQ51068461-ED54CB87-EB5C-49E8-8522-271AFEB30698Q54388219-CBB63DB2-B076-45F7-8A06-77CBD54AB9CAQ57815107-5EBA4AEF-9575-4D10-9884-0DBE3F2013B5
P2860
Hepatocyte survival in acute hepatitis is due to c-Jun/AP-1-dependent expression of inducible nitric oxide synthase
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Hepatocyte survival in acute h ...... nducible nitric oxide synthase
@ast
Hepatocyte survival in acute h ...... nducible nitric oxide synthase
@en
type
label
Hepatocyte survival in acute h ...... nducible nitric oxide synthase
@ast
Hepatocyte survival in acute h ...... nducible nitric oxide synthase
@en
prefLabel
Hepatocyte survival in acute h ...... nducible nitric oxide synthase
@ast
Hepatocyte survival in acute h ...... nducible nitric oxide synthase
@en
P2093
P2860
P356
P1476
Hepatocyte survival in acute h ...... nducible nitric oxide synthase
@en
P2093
Martina Rath
Peter Hasselblatt
Vukoslav Komnenovic
P2860
P304
17105-17110
P356
10.1073/PNAS.0706272104
P407
P577
2007-10-16T00:00:00Z